Headlines News :
Home » » Hepatitis C

Hepatitis C

International Alhijamah Therapist Association - www.i-ata. org - is a disease affecting 20% of patients with viral hepatitis and the remainder in the case of blood transfusion. Incubation for 14-182 days, averaging 42-49 days.

Causes Hepatitis C virus (HCV). Transmitted through sexual intercourse. Contact with infected blood 

SYMPTOMS Most people do not have acute symptoms. 20% had jaundice, 30% experience flu-like symptoms. Experience swelling of the liver. 

Diagnosis Asked if it found the symptoms of hepatitis virus it will do a blood test to confirm the diagnosis and the type of virus. In the event of chronic hepatitis, it is advisable to do a biopsy. 

Treatment Standard therapy used is a combination of pegylated interferon alfa (PEG-IFN alpha) and ribavirin. 
Patients with chronic HCV genotype 1 has a weak response to treatment that is given to 12 months of therapy, whereas patients with HCV genotypes 2 and 3 are given adequate therapy is not only just 6. 
For patients with acute HCV infection are given treatment for 6 months. 
antiviral medications may help shorten clinical symptoms, prevent complications, prevent recurrent / latent phase, lower deployment. These drugs include Ribavirin, boceprevir, Telaprevir 
Giving interferon may help as well, such as Interferon alfa-2b, interferon alfacon-1, peginterferon alfa-2b, pegylated interferon alfa-2a 

PREVENTION There is no vaccine for hepatitis C. The way to prevent is to reduce the risk of exposure to the virus is to prevent needle sharing behavior or personal tools such as toothbrushes, razors and nail clippers with an infected person.
Share this post :

Posting Komentar

Support : Creating Website | IAHTA | International Al-Hijama Therapis Association
Copyright © 2011. IAHTA - All Rights Reserved
Template Created by Creating Website Published by IAHTA
Proudly powered by IAHTA